BioCentury
ARTICLE | Clinical News

BioChaperone PDGF-BB: Development halted

September 5, 2016 7:00 AM UTC

Adocia said it will halt development of BioChaperone PDGF-BB to treat diabetic foot ulcers after top-line data from a double-blind, Indian Phase III trial in 252 patients showed that 4 ug/cm 2 BioChap...